Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICO: Phenylalanine Impact on Cognition in Adult PKU
NCT03788343Phase 4Completed
- Sponsor
- Insel Gruppe
- Start
- Aug 2019
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Insel Gruppe. Primary endpoint: Working memory (accuracy) at 12 weeks. Started Aug 2019; status: completed.
Beyond the preview
Go deeper on NCT03788343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03788343.